Windlas Biotech shares have gained nearly 9% in the last three months. SEBI-registered analyst Finkhoz is bullish on the stock, driven by its improving fundamental strength and a bullish chart setup.
Windlas Biotech Ltd (Windlas) has quietly positioned itself as one of the more interesting mid-cap plays on India’s pharmaceuticals outsourcing wave. The company, headquartered in Dehradun, is ...
WINDLAS BIOTECH LTD - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2025. - Rediff MoneyWiz, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.